Allogene Therapeutics, Inc. (ALLO) Revenue History
Allogene Therapeutics, Inc. (ALLO) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | $38.49M |
| 2022-12-31 | $156.00K |
| 2023-12-31 | $95.00K |
| 2024-12-31 | $22.00K |
| 2025-12-31 | N/A |
How ALLO compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | $3.02M |
| VTGN | Vistagen Therapeutics Inc. | $1.27M |
| RFL | Rafael Holdings Inc. Class B | $917.00K |
| MNOV | MediciNova Inc. | $409.66K |
| PLSE | Pulse Biosciences Inc | $350.00K |
These are five companies in the same sector as ALLO with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Allogene Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("ALLO", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ALLO | $1.44 | -1.25% | 2.60M |
| 3 | ||||
| 4 | ||||
| 5 |